InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Rich Stuart, Directeur Médical. Director active across 1 company, notably Tenax Therapeutics, INC.. Cumulatively, 5 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €29k. Activity tracked since 12 October 2021. The latest transaction was disclosed on 8 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Rich Stuart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,500 shares@ US$10.100273.7% of flowCommon StockSEC:0001841785-25-000004:0
Canonical exit: 8 Mar 2026 (T+90)
1,000 shares@ US$9.0059100.0% of flowCommon StockSEC:0001841785-25-000003:0
Canonical exit: 2 Mar 2026 (T+90)
1,909,585 shares0Common StockSEC:0001654954-22-012922:0
1,909,585 shares0Common StockSEC:0001654954-21-012861:0
3,581,000 sharesCommon StockSEC:0001654954-21-006927:0
5 of 5 declarations
About Rich Stuart
Rich Stuart is the Chief Medical Officer of TENAX THERAPEUTICS, INC. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Rich brings significant expertise in the medical field, contributing to the mission of TENAX THERAPEUTICS, INC.
